Assessment of Real-World Outcomes Associated with Afatinib (Gilotrif) Use in Patients with Solid Tumors Harboring NRG1 Gene Fusions (Afatinib (Gilotrif) Use in Solid Tumors Harboring)

23/09/2021
23/04/2024
EU PAS number:
EUPAS43164
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

Final Protocol_NIS_1200.335_Afatinib_NRG1

English (1.08 MB - PDF) View document
Study results
Study results

CHSS_BI NRG1 CRF_Final Study Report

English (3.26 MB - PDF) View document
Study report
Other information